Development of multiple cutaneous immune-related adverse events among cancer patients after immune checkpoint blockade: Supplemental File

Published: 4 January 2023| Version 2 | DOI: 10.17632/r4bsshkm6w.2
Contributors:
Maria Asdourian, Nishi Shah, Ted Jacoby, Yevgeniy Semenov, Tracey Otto, Leah Thompson, Edward Christopher Dee, Kerry Reynolds, Steven Chen

Description

These files discuss additional methodological details and include two supplemental tables, the first summarizing cirAE characteristics in patients who developed multiple cirAEs after ICI therapy, and the second describing demographic and baseline clinical characteristics of all patients.

Files

Categories

Oncology, Dermatological Disease, Adverse Event, Medical Dermatology, Immune Checkpoint Blockade

Licence